You are here

Article Text

Article menu

Download PDFPDF

Case report
COVID-19-associated central retinal vein occlusion treated with oral aspirin
  1. Ramesh Venkatesh1,
  2. Nikitha Gurram Reddy1,
  3. Sameeksha Agrawal1 and
  4. Arpitha Pereira2
  1. 1Department of Retina and Vitreous, Narayana Nethralaya, Bengaluru, Karnataka, India
  2. 2Ophthalmology, Betsi Cadwaladr University Health Board, Abergele, UK
  1. Correspondence to Dr Arpitha Pereira; arpitha.pereira{at}wales.nhs.uk

Abstract

This is a case report of central retinal vein occlusion (CRVO) associated with COVID-19 treated with oral aspirin therapy. A 56-year-old woman reported decreased vision in her left eye. Her left eye vision was 6/18, N10. Anterior segment was within normal limits. Left eye fundus was suggestive of CRVO and macular oedema. Optical coherence tomography showed cystoid macular oedema and neurosensory detachment. Blood work-up revealed elevated D-dimer levels and erythrocyte sedimentation rate (ESR). She was started on treatment with low-dose aspirin 150 mg/day. After 1 month, her vision improved to 6/6, N6. Left eye fundus showed reduced retinal haemorrhages and complete resolution of macular oedema. Her repeat blood work-up showed reduced D-dimer and ESR levels. The patient was asked to be reviewed after 3 months. This case highlights that specific treatment for reducing the hypercoagulable state caused by COVID-19 with oral aspirin therapy can result in complete resolution of CRVO macular oedema.

  • venous thromboembolism
  • COVID-19
  • macula
  • retina

This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.

https://bmj.com/coronavirus/usage

https://doi.org/10.1136/bcr-2021-242987

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors RV—conceptualising the study, data acquisition, analysing the data, interpreting the findings, writing and reviewing the manuscript. AP—critical reviewing of the manuscript. NGR and SA—data acquisition.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.